LITTLETON, Colo.–(BUSINESS WIRE)–Zynex, Inc. (OTCBB: ZYXI), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that Anthony Scalese has been named Chief Financial Officer. Mr. Scalese will start on September 7, 2010, and will report directly to Thomas Sandgaard, Chief Executive Officer.
“Anthony brings a unique… Continue reading »
Aug. 17 (Bloomberg) — Stryker Corp., a maker of artificial hips and knees, is in advanced talks to buy Boston Scientific Corp.’s pain-management device unit for about $1.5 billion, said three people with knowledge of the transaction.
An agreement for the business, also called the neuromodulation unit, may be announced next week, said the… Continue reading »
Johnson & Johnson (JNJ) said Monday it plans to bolster its lineup of stroke-prevention products by buying Micrus Endovascular Corp. (MEND) for about $480 million, marking the latest deal in a neurovascular-device market that appears to be heating up.
J&J’s planned purchase of San Jose, Calif.-based Micrus comes weeks after rival Covidien PLC (COV)… Continue reading »
MINNEAPOLIS–(BUSINESS WIRE)–Medtronic (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(K) clearance and U.S. launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions.
Providing real-time imaging in the operating room (OR), the PoleStar Surgical MRI provides surgeons with targeting and navigational accuracy despite the anatomy… Continue reading »
Connecticut Innovations today said it has invested $750,000 in New Haven-based Axerion Therapeutics Inc., a Yale University spinoff that is developing treatments for neurological injuries and diseases.
Axerion was founded by Scheer & Co., and Yale faculty member Stephen Strittmatter. Life sciences advisory and venture capital firm Scheer, also located in New Haven, has… Continue reading »
HAWTHORNE, N.Y., Mar 22, 2010 (BUSINESS WIRE) — Acorda Therapeutics, Inc. (ACOR 34.95, +0.11, +0.32%)today announced that the Company has submitted applications to extend patent protection for AMPYRA(TM) (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office (USPTO).
AMPYRA was approved by the U.S. Food and Drug Administration… Continue reading »
LITTLETON, Colo., Mar 22, 2010 (BUSINESS WIRE) — Zynex, Inc. (ZYXI 0.79, -0.04, -4.27%), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that Zynex, Inc. and its subsidiary, Zynex Medical, have entered into a new 3-year revolving credit facility of up to $3.5 million with CapitalSource Bank… Continue reading »
The Cleveland Clinic has received a $1 million federal grant to research treatments for spinal cord injuries.
The National Institutes of Health grant will help lead investigator Yu-Shang Lee develop surgical treatments that might allow nerves to regenerate and the bladder to recover after a spinal cord injury.
“In our laboratory, we have… Continue reading »
ScienceDaily (Feb. 24, 2010) — Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of theJournal of Neuroscience.
In spinal cord injury, demyelination, or the destruction of… Continue reading »
HAWTHORNE, N.Y., Feb 22, 2010 (BUSINESS WIRE) — Acorda Therapeutics, Inc. (ACOR 31.71, -0.23, -0.72%)announced today that Adrian L. Rabinowicz, M.D., FAAN, has joined the Company as Senior Vice President and Head, Medical Affairs, reporting to Thomas Wessel, M.D., Ph.D., Chief Medical Officer. Dr. Rabinowicz will have responsibility for Acorda’s Medical Communications and Scientific… Continue reading »
Two recent studies by neuroscientists at the University of California, Irvine, have had startling success with a neuroregenerative therapy tested in rats. The therapy may eventually help restore limb function in people with impaired mobility, long after they have experienced a stroke, traumatic injury, or the onset of neurodegenerative disease, such as Parkinson’s. NeuroRepair owns
PITTSBURGH, Feb. 4 /PRNewswire/ — Defense Technology International, an influential publication serving the defense and military markets, says medical device manufacturer Neuro Kinetics, Inc. (www.neuro-kinetics.com) is a company “to watch” for its research into new methods of detecting traumatic brain injuries (TBI) and mild traumatic brain injuries (mTBI) in wounded combat soldiers… Continue reading »
ST. PAUL, Minn., Feb 03, 2010 (BUSINESS WIRE) —-St. Jude Medical, Inc. (NYSE:STJ) today announced the U.S. Food and Drug Administration (FDA) clearance of the Swift-Lock(TM) anchor, a new product designed to help physicians efficiently secure neurostimulation leads utilized in spinal cord stimulation (SCS) therapy for the management of chronic pain. Introduced at the American… Continue reading »
FARMINGDALE, N.Y., Feb. 3 /PRNewswire-FirstCall/ — Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Neuro Orthopaedics Surgeries, based near Rio de Janeiro, Brazil, for the distribution… Continue reading »
HAWTHORNE, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced today that Lauren Sabella has joined the Company as Executive Vice President, Commercial Development, reporting to Ron Cohen, M.D., President and Chief Executive Officer. Ms. Sabella will have responsibility for Acorda’s commercial operations, including Marketing, Sales and Managed Markets.
“I’m delighted to welcome Lauren Sabella to… Continue reading »